Article
Author(s):
Levetiracetam is an anticonvulsant used to treat epileptic seizures.
Medication Pearl of the Day: Levetiracetam (Keppra)
Indication: Levetiracetam (Keppra) is indicated for adjunctive therapy in the treatment of partial onset seizures in patients 1 month of age and older with epilepsy; for myoclonic seizures in patients 12 years of age and older with juvenile myoclonic epilepsy; and for primary generalized tonic-clonic seizures in patients 6 years of age and older with idiopathic generalized epilepsy.
Insight:
Reference: label (fda.gov)
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
FDA Grants Full Approval to mRNA-1273 COVID-19 Vaccine in Children At Increased Risk